Adoptive Immunotherapy
Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
Also Known As:
Immunotherapy, Adoptive; CAR T-Cell Therapy; Cellular Immunotherapy, Adoptive; Chimeric Antigen Receptor Therapy; Immunotherapy, Adoptive Cellular; Adoptive Cellular Immunotherapies; Adoptive Immunotherapies; CAR T Cell Therapy; CAR T-Cell Therapies; Cellular Immunotherapies, Adoptive; Immunotherapies, Adoptive; Immunotherapies, Adoptive Cellular; T-Cell Therapies, CAR; T-Cell Therapy, CAR; Therapies, CAR T-Cell; Therapy, CAR T-Cell; Adoptive Cellular Immunotherapy
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Context: Research Results